skip to main content


Title: A preliminary regional PBPK model of lung metabolism for improving species dependent descriptions of 1,3-butadiene and its metabolites

1,3-Butadiene (BD), a volatile organic chemical (VOC), is used in synthetic rubber production and other industrial processes. It is detectable at low levels in ambient air as well as in tobacco smoke and gasoline vapors. Inhalation exposures to high concentrations of BD have been associated with lung cancer in both humans and experimental animals, although differences in species sensitivity have been observed. Metabolically active lung cells such as Pulmonary Type I and Type II epithelial cells and club cells (Clara cells) 1 are potential targets of BD metabolite-induced toxicity. Metabolic capacities of these cells, their regional densities, and distributions vary throughout the respiratory tract as well as between species and cell types. Here we present a physiologically based pharmacokinetic (PBPK) model for BD that includes a regional model of lung metabolism, based on a previous model for styrene, to provide species-dependent descriptions of BD metabolism in the mouse, rat, and human. Since there are no in vivo data on BD pharmacokinetics in the human, the rat and mouse models were parameterized to the extent possible on the basis of in vitro metabolic data. Where it was necessary to use in vivo data, extrapolation from rat to mouse was performed tomore » evaluate the level of uncertainty in the human model. A kidney compartment and description of downstream metabolism were also included in the model to allow for eventual use of available urinary and blood biomarker data in animals and humans to calibrate the model for estimation of BD exposures and internal metabolite levels. Results from simulated inhalation exposures to BD indicate that incorporation of differential lung region metabolism is important in describing species differences in pulmonary response and that these differences may have implications for risk assessments of human exposures to BD.« less
 [1] ;  [2] ;  [3] ;  [2] ;  [4] ;  [5] ;  [6] ;  [7]
  1. The Hammer Institutes for Health Research, Research Triangle Park, NC (United States)
  2. Ramboll Environ, Monroe, LA (United States)
  3. Pacific Northwest National Lab. (PNNL), Richland, WA (United States)
  4. Ramboll Environ, Boston, MA (United States)
  5. British American Tobacco Ltd., Southampton (United Kingdom)
  6. R.J. Reynolds Tobacco Co., Winston-Salem, NC (United States)
  7. The Hammer Institutes for Health Research, Research Triangle Park, NC (United States); Ramboll Environ, Monroe, LA (United States)
Publication Date:
Grant/Contract Number:
Accepted Manuscript
Journal Name:
Chemico-Biological Interactions
Additional Journal Information:
Journal Volume: 238; Journal Issue: C; Journal ID: ISSN 0009-2797
Research Org:
Pacific Northwest National Lab. (PNNL), Richland, WA (United States)
Sponsoring Org:
Country of Publication:
United States
37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CHEMISTRY; 59 BASIC BIOLOGICAL SCIENCES; 1,3-Butadiene; physiologically – based pharmacokinetic model; PBPK; lung metabolism
OSTI Identifier: